BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26228098)

  • 1. A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.
    Gesquière-Dando A; Guedj E; Loundou A; Carron R; Witjas T; Fluchère F; Delfini M; Mundler L; Regis J; Azulay JP; Eusebio A
    Mov Disord; 2015 Nov; 30(13):1767-76. PubMed ID: 26228098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study.
    Robert GH; Le Jeune F; Lozachmeur C; Drapier S; Dondaine T; Péron J; Houvenaghel JF; Travers D; Sauleau P; Millet B; Vérin M; Drapier D
    Neurology; 2014 Oct; 83(18):1620-6. PubMed ID: 25253750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
    Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.
    Le Jeune F; Drapier D; Bourguignon A; Péron J; Mesbah H; Drapier S; Sauleau P; Haegelen C; Travers D; Garin E; Malbert CH; Millet B; Vérin M
    Neurology; 2009 Nov; 73(21):1746-51. PubMed ID: 19933975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
    Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
    Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
    Lyoo CH; Aalto S; Rinne JO; Lee KO; Oh SH; Chang JW; Lee MS
    Mov Disord; 2007 Nov; 22(15):2176-82. PubMed ID: 17712844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Langner-Lemercier S; Drapier S; Naudet F; Le Clanche N; Houvenaghel JF; Sauleau P; Jannin P; Haegelen C; Le Jeune F; Vérin M
    J Neurol; 2015; 262(4):881-9. PubMed ID: 25634679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.
    Maier F; Lewis CJ; Horstkoetter N; Eggers C; Dembek TA; Visser-Vandewalle V; Kuhn J; Zurowski M; Moro E; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2016 Mar; 24():41-7. PubMed ID: 26827110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
    Zhao YB; Sun BM; Li DY; Wang QS
    Chin Med J (Engl); 2004 Sep; 117(9):1304-8. PubMed ID: 15377418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
    Béreau M; Kibleur A; Servant M; Clément G; Dujardin K; Rolland AS; Wirth T; Lagha-Boukbiza O; Voirin J; Santin MDN; Hainque E; Grabli D; Comte A; Drapier S; Durif F; Marques A; Eusebio A; Azulay JP; Giordana C; Houeto JL; Jarraya B; Maltete D; Rascol O; Rouaud T; Tir M; Moreau C; Danaila T; Prange S; Tatu L; Tranchant C; Corvol JC; Devos D; Thobois S; Desmarets M; Anheim M
    Brain; 2024 Feb; 147(2):472-485. PubMed ID: 37787488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.
    Haegelen C; García-Lorenzo D; Le Jeune F; Péron J; Gibaud B; Riffaud L; Brassier G; Barillot C; Vérin M; Morandi X
    J Neurol; 2010 Mar; 257(3):375-82. PubMed ID: 19774437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-frontal-insular-cerebellar modifications correlate with disgust feeling blunting after subthalamic stimulation: A positron emission tomography study in Parkinson's disease.
    Ory S; Le Jeune F; Haegelen C; Vicente S; Philippot P; Dondaine T; Jannin P; Drapier S; Drapier D; Sauleau P; Vérin M; Péron J
    J Neuropsychol; 2017 Sep; 11(3):378-395. PubMed ID: 26670087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.
    Fauser M; Ricken M; Markert F; Weis N; Schmitt O; Gimsa J; Winter C; Badstübner-Meeske K; Storch A
    Neurobiol Dis; 2021 Aug; 156():105404. PubMed ID: 34044146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease.
    Péron J; Le Jeune F; Haegelen C; Dondaine T; Drapier D; Sauleau P; Reymann JM; Drapier S; Rouaud T; Millet B; Vérin M
    PLoS One; 2010 Mar; 5(3):e9919. PubMed ID: 20360963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STN-DBS activates the target area in Parkinson disease: an FDG-PET study.
    Hilker R; Voges J; Weber T; Kracht LW; Roggendorf J; Baudrexel S; Hoevels M; Sturm V; Heiss WD
    Neurology; 2008 Sep; 71(10):708-13. PubMed ID: 18650492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
    J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.